American Journal of Clinical Nutrition, Vol 68, 154-163, Copyright © 1998 by The American Society for Clinical Nutrition, Inc

ORIGINAL RESEARCH COMMUNICATIONS

De novo lipogenesis predicts short-term body-composition response by bioelectrical impedance analysis to oral nutritional supplements in HIV- associated wasting

R Hoh, A Pelfini, RA Neese, M Chan, JP Cello, FO Cope, BC Abbruzese, EW Richards, K Courtney and MK Hellerstein
San Francisco General Hospital, Department of Medicine, University of California, 94110, USA.

We studied the effects of enteral supplements on protein and energy intakes, body composition, energy expenditure, and gastrointestinal histology in 49 subjects with human immunodeficiency virus-associated weight loss (12.7 +/- 0.9% of body wt). We also determined whether a stable-isotope mass spectrometric measurement at baseline might predict the short-term response of fat-free mass (FFM) measured by bioelectrical impedance analysis. Thirty-nine subjects completed the study after being randomly assigned to receive either a whole-protein- based (n = 22) or a peptide-based (n = 17) formula. A nonsupplemented, nonrandomly assigned group (n = 13) was followed concurrently. Both formulas were well tolerated. Voluntary intakes of energy and protein from nonsupplement sources decreased significantly during supplementation [by 819-1638 kJ (196-382 kcal)/d and 5.6-14.4 g protein/d, respectively; P < 0.01] but to a lesser extent than the intake from the supplement [2300-2510 kJ(550-600 kcal)/d and 19-28 g protein/d, respectively], so that net increases in intakes of protein and energy (P < 0.03), as well as of several vitamins and trace elements were increased. Nevertheless, the mean FFM did not increase for the group as a whole, although there was considerable interindividual heterogeneity. Changes in FFM at 6 wk were significantly inversely correlated (r = 0.65, P < 0.01) with baseline synthesis of fat (de novo hepatic lipogenesis), but not with other potential measures of energy intake (insulin-like growth factor 1 or its binding protein) or inflammation (soluble tumor necrosis factor receptors I or II). The prospective identification of FFM response by measurement of de novo hepatic lipogenesis supported the hypothesis that the subset of wasting patients whose FFM is unresponsive to nutrient supplementation have altered nutrient metabolism.

This article has been cited by other articles:

				M. J Batterham Investigating heterogeneity in studies of resting energy expenditure in persons with HIV/AIDS: a meta-analysis Am. J. Clinical Nutrition, March 1, 2005; 81(3): 702 - 713. [Abstract] [Full Text] [PDF]

				R. M McDevitt, S. J Bott, M. Harding, W A. Coward, L. J Bluck, and A. M Prentice De novo lipogenesis during controlled overfeeding with sucrose or glucose in lean and obese women Am. J. Clinical Nutrition, December 1, 2001; 74(6): 737 - 746. [Abstract] [Full Text]

				M. A. van Bokhorst-de van der Schueren, J. J Quak, B M. E von Blomberg-van der Flier, D. J Kuik, S. I Langendoen, G. B Snow, C. J Green, and P. A. van Leeuwen Effect of perioperative nutrition, with and without arginine supplementation, on nutritional status, immune function, postoperative morbidity, and survival in severely malnourished head and neck cancer patients Am. J. Clinical Nutrition, February 1, 2001; 73(2): 323 - 332. [Abstract] [Full Text] [PDF]

				A. Strawford, T. Barbieri, M. Van Loan, E. Parks, D. Catlin, N. Barton, R. Neese, M. Christiansen, J. King, and M. K. Hellerstein Resistance Exercise and Supraphysiologic Androgen Therapy in Eugonadal Men With HIV-Related Weight Loss: A Randomized Controlled Trial JAMA, April 14, 1999; 281(14): 1282 - 1290. [Abstract] [Full Text] [PDF]